These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 16827845)

  • 1. Tacrolimus and sirolimus: when bad things happen to good drugs.
    Kaplan B; Kirk AD
    Am J Transplant; 2006 Jul; 6(7):1501-2. PubMed ID: 16827845
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pro- and antitumor effects of the main immunosuppressive drugs used in the clinical practice of transplantation].
    Marchini F
    G Ital Nefrol; 2007; 24(2):171. PubMed ID: 17458835
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term renal allograft function on a tacrolimus-based, pred-free maintenance immunosuppression comparing sirolimus vs. MMF.
    Gallon L; Perico N; Dimitrov BD; Winoto J; Remuzzi G; Leventhal J; Gaspari F; Kaufman D
    Am J Transplant; 2006 Jul; 6(7):1617-23. PubMed ID: 16827862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term kidney allograft function and survival in prednisone-free regimens: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.
    Chhabra D; Skaro AI; Leventhal JR; Dalal P; Shah G; Wang E; Gallon L
    Clin J Am Soc Nephrol; 2012 Mar; 7(3):504-12. PubMed ID: 22282478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What does the CONVERT trial really tell us about conversion from calcineurin inhibitors to sirolimus?
    Hanto DW; Chudzinski R
    Transplantation; 2009 Jan; 87(2):164-5. PubMed ID: 19155968
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of sirolimus and tacrolimus on mortality and graft loss in liver transplant recipients with or without hepatitis C virus: an analysis of the Scientific Registry of Transplant Recipients Database.
    Watt KD; Dierkhising R; Heimbach JK; Charlton MR
    Liver Transpl; 2012 Sep; 18(9):1029-36. PubMed ID: 22641474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined effects of calcineurin inhibitors or sirolimus with anti-CD40L mAb on alloengraftment under nonmyeloablative conditions.
    Taylor PA; Lees CJ; Wilson JM; Ehrhardt MJ; Campbell MT; Noelle RJ; Blazar BR
    Blood; 2002 Nov; 100(9):3400-7. PubMed ID: 12384443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteinuria among primarily sirolimus treated live-donor renal transplant recipients' long-term experience.
    Hamdy AF; Bakr MA; Ghoneim MA
    Exp Clin Transplant; 2010 Dec; 8(4):283-91. PubMed ID: 21143093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective analysis of a sirolimus/prograf regimen for the prevention of acute rejection in recipients of primary mismatched renal allografts.
    Youseff N; Small S
    Transplant Proc; 2002 Aug; 34(5):1653-5. PubMed ID: 12176522
    [No Abstract]   [Full Text] [Related]  

  • 11. Decreased acute rejection and improved renal allograft survival using sirolimus and low-dose calcineurin inhibitors without induction therapy.
    Tsai MK; Wu FL; Lai IR; Lee CY; Hu RH; Lee PH
    Int J Artif Organs; 2009 Jun; 32(6):371-80. PubMed ID: 19670189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tacrolimus-associated optic neuropathy after pancreatic islet transplantation using a sirolimus/tacrolimus immunosuppressive regimen.
    Kessler L; Lucescu C; Pinget M; Charton MN; Mutschler V; Wolf P; Berney T; Benhamou PY;
    Transplantation; 2006 Feb; 81(4):636-7. PubMed ID: 16495816
    [No Abstract]   [Full Text] [Related]  

  • 13. Thrombotic microangiopathy associated with combined sirolimus and tacrolimus immunosuppression after intestinal transplantation.
    Paramesh AS; Grosskreutz C; Florman SS; Gondolesi GE; Sharma S; Kaufman SS; Fishbein TM
    Transplantation; 2004 Jan; 77(1):129-31. PubMed ID: 14724447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative, randomized trial of concentration-controlled sirolimus combined with reduced-dose tacrolimus or standard-dose tacrolimus in renal allograft recipients.
    Bechstein WO; Paczek L; Wramner L; Squifflet JP; Zygmunt AJ;
    Transplant Proc; 2013; 45(6):2133-40. PubMed ID: 23953523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acne keloidalis nuchae in renal transplant patients receiving tacrolimus and sirolimus.
    Pirmez R; Price VH; Cuzzi T; Trope BM
    Australas J Dermatol; 2016 May; 57(2):156-7. PubMed ID: 27124649
    [No Abstract]   [Full Text] [Related]  

  • 16. Wound-healing complications after kidney transplantation: a prospective, randomized comparison of sirolimus and tacrolimus.
    Dean PG; Lund WJ; Larson TS; Prieto M; Nyberg SL; Ishitani MB; Kremers WK; Stegall MD
    Transplantation; 2004 May; 77(10):1555-61. PubMed ID: 15239621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombotic microangiopathy after GVHD prophylaxis with tacrolimus/sirolimus: a call for use of consensus definition in reporting.
    Kharfan-Dabaja MA; Pidala J; Anasetti C
    Blood; 2010 May; 115(21):4316-7; author reply 4317. PubMed ID: 20508174
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of Sirolimus Combined With Tacrolimus and Mycophenolate Mofetil Combined With Tacrolimus in Kidney Transplantation Recipients: A Meta-Analysis.
    Gao L; Xu F; Cheng H; Liu J
    Transplant Proc; 2018 Dec; 50(10):3306-3313. PubMed ID: 30577200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kidney function and morphology after short-term combination therapy with cyclosporine A, tacrolimus and sirolimus in the rat.
    Nielsen FT; Ottosen P; Starklint H; Dieperink H
    Nephrol Dial Transplant; 2003 Mar; 18(3):491-6. PubMed ID: 12584269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of immunosuppressive drugs on spontaneous DNA repair in human peripheral blood mononuclear cells.
    Ori Y; Herman-Edelstein M; Zingerman B; Rozen-Zvi B; Gafter U; Malachi T; Gafter-Gvili A
    Biomed Pharmacother; 2012 Sep; 66(6):409-13. PubMed ID: 22795807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.